CHF Solutions’ Aquadex FlexFlow® Aquapheresis System Receives FDA IDE Approval for Clinical Study for Pediatric Use

NEXT STORY
Is female genital cosmetic surgery going mainstream?
PREV STORY
Colonoscopy patients prefer propofol over fentanyl/midazolam
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aravive to Host Key Opinion Leader Breakfast Symposium on AVB-S6-500 and the GAS6-AXL Pathway on February 5, 2019

HOUSTON, Jan. 29, 2019 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News

ADMA Biologics Retires Approximately 8.6 Million Shares Previously Issued to Biotest

Capital Structure Improved as Total Outstanding Common Stock Reduced By Approximately 19%RAMSEY, N.J. and ...

author_avatar
NASDAQ Market News

MediWound Reports Fourth Quarter and Fiscal Year 2017 Financial Results

NexoBrid® sales grow 60% in 2017 vs. 2016 Raised gross proceeds of $25.2 million ...

author_avatar
NASDAQ Market News